Zhejiang Tianyu Pharmaceutical Future Growth
Future criteria checks 4/6
Zhejiang Tianyu Pharmaceutical is forecast to grow earnings and revenue by 91.9% and 17.8% per annum respectively while EPS is expected to grow by 91.9% per annum.
Key information
91.9%
Earnings growth rate
91.9%
EPS growth rate
Pharmaceuticals earnings growth | 18.6% |
Revenue growth rate | 17.8% |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | 29 Apr 2024 |
Recent future growth updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2025 | 3,353 | 321 | N/A | 537 | 3 |
12/31/2024 | 2,908 | 277 | N/A | 321 | 3 |
3/31/2024 | 2,440 | -32 | -120 | 118 | N/A |
12/31/2023 | 2,527 | 27 | -361 | -44 | N/A |
9/30/2023 | 2,447 | -89 | -571 | -232 | N/A |
3/31/2023 | 2,694 | -103 | -557 | 40 | N/A |
12/31/2022 | 2,667 | -119 | -576 | -49 | N/A |
9/30/2022 | 2,690 | 37 | -519 | -31 | N/A |
6/30/2022 | 2,652 | 119 | -542 | -29 | N/A |
3/31/2022 | 2,536 | 156 | -880 | -340 | N/A |
1/1/2022 | 2,545 | 205 | -999 | -262 | N/A |
9/30/2021 | 2,523 | 295 | -924 | -39 | N/A |
6/30/2021 | 2,623 | 466 | -613 | 189 | N/A |
3/31/2021 | 2,778 | 634 | -335 | 364 | N/A |
12/31/2020 | 2,587 | 667 | 116 | 622 | N/A |
9/30/2020 | 2,532 | 719 | 187 | 514 | N/A |
6/30/2020 | 2,464 | 713 | 258 | 515 | N/A |
3/31/2020 | 2,181 | 624 | 203 | 509 | N/A |
12/31/2019 | 2,111 | 586 | 74 | 428 | N/A |
9/30/2019 | 2,046 | 529 | 79 | 465 | N/A |
6/30/2019 | 1,799 | 377 | -1 | 350 | N/A |
3/31/2019 | 1,666 | 271 | -28 | 230 | N/A |
12/31/2018 | 1,467 | 164 | -101 | 79 | N/A |
9/30/2018 | 1,309 | 73 | -119 | 28 | N/A |
6/30/2018 | 1,226 | 65 | -89 | 7 | N/A |
3/31/2018 | 1,201 | 89 | -17 | 87 | N/A |
12/31/2017 | 1,188 | 100 | N/A | 102 | N/A |
9/30/2017 | 1,149 | 128 | N/A | 78 | N/A |
3/31/2017 | 1,055 | 109 | N/A | 108 | N/A |
12/31/2016 | 1,082 | 122 | N/A | 165 | N/A |
12/31/2015 | 840 | 50 | N/A | 15 | N/A |
12/31/2014 | 777 | 24 | N/A | 80 | N/A |
12/31/2013 | 723 | 34 | N/A | 40 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 300702 is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.9%).
Earnings vs Market: 300702 is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: 300702 is expected to become profitable in the next 3 years.
Revenue vs Market: 300702's revenue (17.8% per year) is forecast to grow faster than the CN market (14.6% per year).
High Growth Revenue: 300702's revenue (17.8% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if 300702's Return on Equity is forecast to be high in 3 years time